Fibrobiologics Inc (FBLG) Stock Price, Quote & News

Company Profile

FibroBiologics, Inc., a clinical-stage biotechnology company, engages in the development and commercialization of fibroblast-based therapies for patients suffering from chronic diseases. The company's product pipeline includes CYWC628 which has completed pre-clinical trial for the treatment of wound healing; CYMS101 which has completed Phase 1 trial for the treatment of multiple sclerosis; CybroCell for the treatment of degenerative disc disease; and CYPS317 for the treatment of psoriasis. It al...

Industry: Biotechnology

Sector: Healthcare

Phone: 281 671 5150

Website: fibrobiologics.com

Address:

455 East Medical Center Boulevard, Suite 300, Houston, United States

McMillion1 Jul. 28 at 1:12 AM

$GOSS This could go up to $1.5….NFA $FDMT $VIR $IOVA $FBLG

3 · Reply

ysf112 Jul. 27 at 6:17 PM

$FBLG yükseliş beklerken tam tersine düşüş yapıyor.Kaç zamandır yukarı yönlü hareket beklendi.

1 · Reply

KardiTheViking Jul. 27 at 10:19 AM

$FBLG stock has gone down for two years. Then when hit oversold at cents, they messed up three times with rallies not allowing price to go above 1$ (before RS). As soon as they see price go up a bit they do an offering. No body is willing to go long term. I am in until the trial results, but I see this as dead money (gone)

0 · Reply

KardiTheViking Jul. 27 at 10:14 AM

$FBLG these guys are like the Titanic full speed towards the iceberg, it’s their own company and every choice hurts the stock price

0 · Reply

Enoch120 Jul. 24 at 9:54 PM

$FBLG Here we go again, delisting notice. How will the company respond?

0 · Reply

MisoHawny Jul. 23 at 3:03 PM

$FBLG 0.735 hit. Theyre not done. 0.72 next. It might take some time.

1 · Reply

MisoHawny Jul. 21 at 3:08 PM

$FBLG hmmm….

0 · Reply

Niddi Jul. 16 at 1:37 AM

$FBLG Being manipulated. Both bid and ask prices are set by these manipulators all day long. Corrupt!!!

0 · Reply

Darksoul Jul. 16 at 12:43 AM

$FBLG whats going on here people just think there is zero chance for these trials to be successful ? FFS...

0 · Reply

MisoHawny Jul. 9 at 12:53 PM

$FBLG good news recently yet we are down to .8 this morning……hmmmm…..

0 · Reply

FibroBiologics Proxy statement: Proxy filing

Jul 10, 2026, 8:00 AM EDT - 20 days ago

FibroBiologics Registration statement: Registration filing

2026-07-10T11:25:14.000Z - 20 days ago

FibroBiologics files to sell up to 12.53M shares of common stock

2026-07-09T12:41:41.000Z - 21 days ago

FibroBiologics appoints Rubins to its Board of Directors

Jul 9, 2026, 8:30 AM EDT - 21 days ago

FibroBiologics Appoints Kathleen "Kate" Rubins, Ph.D. to Board of Directors

2026-07-07T12:40:57.000Z - 23 days ago

FibroBiologics completes manufacturing of third batch of CYWC628

Jul 7, 2026, 8:30 AM EDT - 23 days ago

FibroBiologics Completes Manufacturing of Third Batch of CYWC628 Drug Product for Phase 1/2 Diabetic Foot Ulcer Clinical Trial

Jun 30, 2026, 8:30 AM EDT - 4 weeks ago

FibroBiologics to Participate in Fireside Chat at H.C. Wainwright 4th Annual Cell Therapy Virtual Conference

Jun 29, 2026, 4:01 PM EDT - 4 weeks ago

FibroBiologics Announces Closing of up to $9.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules

2026-06-26T12:40:14.000Z - 4 weeks ago

FibroBiologics announces $9M private placement priced at-the-market

Jun 26, 2026, 8:30 AM EDT - 4 weeks ago

FibroBiologics Announces up to $9.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules

Jun 22, 2026, 12:00 PM EDT - 5 weeks ago

FibroBiologics Transcript: AGM 2026

2026-06-22T13:39:09.000Z - 5 weeks ago

FibroBiologics receives notice of allowance for U.S. patent

Jun 22, 2026, 8:30 AM EDT - 5 weeks ago

FibroBiologics Receives Notice of Allowance for U.S. Patent Covering Topical Fibroblast Spheroid Therapy for Wound Healing

2026-06-16T12:58:52.000Z - 6 weeks ago

FibroBiologics doses first patients in CYWC628 clinical trial

Jun 16, 2026, 8:30 AM EDT - 6 weeks ago

FibroBiologics Advances Patient Dosing for Phase 1/2 Clinical Trial of CYWC628 for the Treatment of Diabetic Foot Ulcers

2026-06-03T12:30:49.000Z - 2 months ago

FibroBiologics doses first patients in CYWC628 trial

Jun 3, 2026, 7:00 AM EDT - 2 months ago

FibroBiologics Announces First Patients Dosed in Phase 1/2 Clinical Trial Evaluating CYWC628 for the Treatment of Diabetic Foot Ulcers

2026-05-22T12:45:44.000Z - 2 months ago

FibroBiologics presents preclinical data from CYPS317 program

May 22, 2026, 8:30 AM EDT - 2 months ago

FibroBiologics Presents Preclinical Data Demonstrating Durable Immunomodulation in Psoriasis at the Society for Investigative Dermatology 2026 Annual Meeting

May 18, 2026, 8:30 AM EDT - 2 months ago

FibroBiologics Files Patent Application for Oral Administration of Fibroblast Therapeutics

2026-05-11T14:42:59.000Z - 2 months ago

FibroBiologics expands fibroblast-based platform to target Hantavirus

May 11, 2026, 8:30 AM EDT - 2 months ago

FibroBiologics Advancing Development of a Fibroblast Treatment for Hantavirus

May 5, 2026, 8:30 AM EDT - 3 months ago

FibroBiologics CEO Issues Letter to Shareholders

May 5, 2026, 8:00 AM EDT - 3 months ago

FibroBiologics Proxy statement: Proxy filing

May 5, 2026, 8:00 AM EDT - 3 months ago

FibroBiologics Proxy statement: Proxy filing

2026-05-04T21:05:51.000Z - 3 months ago

FibroBiologics says fibroblast spheroids drive burn healing, reduce scarring

May 4, 2026, 4:01 PM EDT - 3 months ago

FibroBiologics Reports Preclinical Data Showing Fibroblast Spheroids May Actively Reprogram the Burn Wound Environment to Drive Healing and Reduce Scarring

2026-05-04T13:30:12.000Z - 3 months ago

FibroBiologics releases first batch of CYWC628 for Phase 1/2 trial

May 4, 2026, 8:30 AM EDT - 3 months ago

FibroBiologics Announces Release of CYWC628 Drug Product for Phase 1/2 Diabetic Foot Ulcer Clinical Trial

2026-05-04T12:28:08.000Z - 3 months ago

FibroBiologics downgraded to Hold from Buy at Maxim

2026-04-30T22:00:27.000Z - 3 months ago

FibroBiologics reports Q1 net loss roughly ($5M)

Apr 30, 2026, 5:55 PM EDT - 3 months ago

FibroBiologics Reports Q1 2026 Financial Results and Provides Corporate Update

Apr 30, 2026, 8:30 AM EDT - 3 months ago

FibroBiologics Announces Poster Presentation at the Society for Investigative Dermatology Annual Meeting 2026

Apr 30, 2026, 7:00 AM EDT - 3 months ago

FibroBiologics Quarterly report: Q1 2026

Apr 30, 2026, 7:00 AM EDT - 3 months ago

FibroBiologics Earnings release: Q1 2026

Apr 22, 2026, 8:00 AM EDT - 3 months ago

FibroBiologics Proxy statement: Proxy filing

2026-04-20T20:23:12.000Z - 3 months ago

FibroBiologics announces compliance with all Nasdaq listing requirements

Apr 20, 2026, 4:01 PM EDT - 3 months ago

FibroBiologics Compliant with All Nasdaq Listing Requirements

2026-04-16T14:53:32.000Z - 3 months ago

FibroBiologics target adjusted to $8 at H.C. Wainwright after reverse split

Apr 10, 2026, 8:30 AM EDT - 3 months ago

FibroBiologics Presents Novel Thymus Organoid Platform to Combat Age-Related Immune Decline at Keystone Symposia on Aging and Immunity

Apr 2, 2026, 4:01 PM EDT - 4 months ago

FibroBiologics Announces Closing of $3 Million Public Offering

2026-04-01T00:05:13.000Z - 4 months ago

FibroBiologics prices $3M public offering

Mar 31, 2026, 8:00 PM EDT - 4 months ago

FibroBiologics Announces Pricing of $3 Million Public Offering

2026-03-31T20:41:40.000Z - 4 months ago

FibroBiologics manufactures first batch of CYWC628 drug product for trials

Mar 31, 2026, 4:15 PM EDT - 4 months ago

FibroBiologics Announces Successful Manufacturing of CYWC628 Drug Product to Support Upcoming Diabetic Foot Ulcer Clinical Trial

2026-03-27T23:50:16.000Z - 4 months ago

Fibrobiologics Inc trading halted, news pending

2026-03-27T21:25:14.000Z - 4 months ago

FibroBiologics files to sell 1.14M shares of common stock, warrants

Mar 27, 2026, 8:00 AM EDT - 4 months ago

FibroBiologics Registration statement: Registration filing

Mar 25, 2026, 4:30 PM EDT - 4 months ago

FibroBiologics Announces Reverse Stock Split to Regain Compliance with Nasdaq's Bid Price Requirement

Mar 12, 2026, 8:30 AM EDT - 5 months ago

FibroBiologics Announces Advances in Burn Treatment Using Proprietary Fibroblast Spheroid Technology

$FibroBiologics Completes Site Onboarding for Phase 1/2 Clinical Trial for CYWC628 for the Treatment of Refractory Diabetic Foot Ulcers$

Mar 5, 2026, 8:30 AM EST - 5 months ago

FibroBiologics Completes Site Onboarding for Phase 1/2 Clinical Trial for CYWC628 for the Treatment of Refractory Diabetic Foot Ulcers

Mar 2, 2026, 8:30 AM EST - 5 months ago

FibroBiologics, Inc. Announces Issuance of U.S. Patent Covering Fibroblast Cell Therapy for the Treatment of Osteoporosis

Feb 26, 2026, 8:30 AM EST - 5 months ago

FibroBiologics to Present at the BIO Investment & Growth Summit

Feb 24, 2026, 4:30 PM EST - 5 months ago

FibroBiologics Reports Full Year 2025 Financial Results and Provides Corporate Update

Feb 24, 2026, 7:00 AM EST - 5 months ago

FibroBiologics Earnings release: Q4 2025

Feb 24, 2026, 7:00 AM EST - 5 months ago

FibroBiologics Annual report: Q4 2025

Feb 24, 2026, 7:00 AM EST - 5 months ago

FibroBiologics Annual report: Q4 2025

Feb 23, 2026, 8:30 AM EST - 5 months ago

FibroBiologics Granted Extension by Nasdaq to Regain Compliance

Feb 20, 2026, 12:00 PM EST - 5 months ago

FibroBiologics Transcript: EGM 2026

Feb 10, 2026, 8:30 AM EST - 6 months ago

FibroBiologics' Chairman & CEO Pete O'Heeron Selected to Present at A4LI's H-SPAN Summit at Georgetown University

Feb 5, 2026, 8:30 AM EST - 6 months ago

FibroBiologics Announces Issuance of Canadian Patent Covering Novel Fibroblast-Based Treatment for Cachexia

Jan 20, 2026, 8:30 AM EST - 6 months ago

FibroBiologics to Present at the DealFlow Discovery Conference

Jan 6, 2026, 8:30 AM EST - 7 months ago

FibroBiologics to Present at 9th Annual BFC Global Healthcare Business Development and Investment Conference

Jan 5, 2026, 8:30 AM EST - 7 months ago

FibroBiologics Announces Positive Preclinical Results for a Fibroblast Spheroid-derived Chondrocyte (FSdC) Spheroid Therapy for Degenerative Disc Disease

Dec 31, 2025, 8:30 AM EST - 7 months ago

FibroBiologics Files IND Application with the U.S. FDA to Advance Clinical Development of CYPS317 in Patients with Psoriasis

Dec 29, 2025, 7:00 AM EST - 7 months ago

FibroBiologics Proxy statement: Proxy Filing

Dec 29, 2025, 7:00 AM EST - 7 months ago

FibroBiologics Proxy statement: Proxy Filing

Dec 23, 2025, 7:00 AM EST - 7 months ago

FibroBiologics Registration statement: Registration Filing

Dec 18, 2025, 7:00 AM EST - 8 months ago

FibroBiologics Proxy statement: Proxy Filing

Dec 18, 2025, 7:00 AM EST - 8 months ago

FibroBiologics Proxy statement: Proxy Filing

Dec 16, 2025, 4:05 PM EST - 8 months ago

FibroBiologics Announces Closing of $1.7 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Dec 15, 2025, 8:00 AM EST - 8 months ago

FibroBiologics Announces $1.7 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Dec 10, 2025, 8:30 AM EST - 8 months ago

FibroBiologics Files Patent Application Covering Novel Fibroblast-Based Chondrocyte Spheroid Platform for Orthopedic and Musculoskeletal Conditions

Nov 26, 2025, 8:30 AM EST - 8 months ago

FibroBiologics Announces Payoff of Outstanding Debt

Nov 25, 2025, 4:05 PM EST - 8 months ago

FibroBiologics Announces Closing of $1.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Nov 24, 2025, 9:00 AM EST - 8 months ago

FibroBiologics Announces $1.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

$FibroBiologics Receives HREC Approval for Phase 1/2 Clinical Trial for CYWC628 for the Treatment of Refractory Diabetic Foot Ulcers$

Nov 20, 2025, 8:00 AM EST - 9 months ago

FibroBiologics Receives HREC Approval for Phase 1/2 Clinical Trial for CYWC628 for the Treatment of Refractory Diabetic Foot Ulcers

Nov 19, 2025, 7:03 PM EST - 9 months ago

FibroBiologics Announces Closing of $4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Nov 19, 2025, 8:36 AM EST - 9 months ago

FibroBiologics Announces Pricing of $4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Oct 31, 2025, 4:30 PM EDT - 9 months ago

FibroBiologics Reports Third Quarter 2025 Financial Results and Provides Corporate Update

Oct 31, 2025, 4:00 PM EDT - 9 months ago

FibroBiologics Earnings release: Q3 2025

Oct 31, 2025, 4:00 PM EDT - 9 months ago

FibroBiologics Quarterly report: Q3 2025

Oct 24, 2025, 8:30 AM EDT - 9 months ago

FibroBiologics to Present at Bio-Europe 2025

Oct 14, 2025, 8:30 AM EDT - 10 months ago

FibroBiologics to Present at the 2025 ThinkEquity Conference

Sep 23, 2025, 8:30 AM EDT - 11 months ago

FibroBiologics to Present at 2025 Cell & Gene Meeting on the Mesa

Sep 12, 2025, 8:30 AM EDT - 11 months ago

FibroBiologics Leadership Authors Opinion Editorial Highlighting Fibroblast Cells' Therapeutic Advantages Over Traditional Stem Cell Therapies

Sep 11, 2025, 8:30 AM EDT - 11 months ago

FibroBiologics Announces Positive IND-Enabling Updates Demonstrating Potential of Fibroblast Spheroids in Chronic-Relapse Psoriasis Treatment

Sep 10, 2025, 8:30 AM EDT - 11 months ago

FibroBiologics Announces Significant Advancements in Bone Marrow Organoid Platform Enabling Development for Cancer and Immune-Related Therapies

McMillion1 Jul. 28 at 1:12 AM

$GOSS This could go up to $1.5….NFA $FDMT $VIR $IOVA $FBLG

3 · Reply

ysf112 Jul. 27 at 6:17 PM

$FBLG yükseliş beklerken tam tersine düşüş yapıyor.Kaç zamandır yukarı yönlü hareket beklendi.

1 · Reply

KardiTheViking Jul. 27 at 10:19 AM

0 · Reply

KardiTheViking Jul. 27 at 10:14 AM

$FBLG these guys are like the Titanic full speed towards the iceberg, it’s their own company and every choice hurts the stock price

0 · Reply

Enoch120 Jul. 24 at 9:54 PM

$FBLG Here we go again, delisting notice. How will the company respond?

0 · Reply

MisoHawny Jul. 23 at 3:03 PM

$FBLG 0.735 hit. Theyre not done. 0.72 next. It might take some time.

1 · Reply

MisoHawny Jul. 21 at 3:08 PM

$FBLG hmmm….

0 · Reply

Niddi Jul. 16 at 1:37 AM

$FBLG Being manipulated. Both bid and ask prices are set by these manipulators all day long. Corrupt!!!

0 · Reply

Darksoul Jul. 16 at 12:43 AM

$FBLG whats going on here people just think there is zero chance for these trials to be successful ? FFS...

0 · Reply

MisoHawny Jul. 9 at 12:53 PM

$FBLG good news recently yet we are down to .8 this morning……hmmmm…..

0 · Reply

Wnt531 Jul. 7 at 5:57 PM

$FBLG Bullish update for $FBLG! Completing the final manufacturing batch means FibroBiologics expects to have enough CYWC628 to finish its Phase 1/2 DFU trial—without additional manufacturing costs. Lower cash burn, greater efficiency, and one more milestone checked off. Looking forward to the clinical data!

1 · Reply

Niddi Jul. 1 at 2:46 PM

$FBLG The sp was obviously manipulated down to $.75 to grant these options and $ 9 million private placement. Now it is so smoothly going above critical value of $1 without problem. All is well, nothing to look here SEC!!!!

0 · Reply

Mountain_Skis Jun. 30 at 10:05 PM

$JEM being patient paid off 🙏🏽 Waiting for $FBLG

0 · Reply

Mountain_Skis Jun. 30 at 3:26 PM

$JEM finally round 3 paid off. $FBLG just needs a solid push 🔥

0 · Reply

MisoHawny Jun. 29 at 7:33 PM

$FBLG 0.73 on deck

0 · Reply

Majid74 Jun. 26 at 10:11 PM

$FBLG why is it again down?

0 · Reply

Enoch120 Jun. 26 at 6:08 PM

$FBLG breathing a little sigh of relief with new lower cost average. i know this will take awhile for trials to advance. 🙏

0 · Reply

JMJTrading Jun. 26 at 4:14 PM

$FBLG

0 · Reply

JMJTrading Jun. 26 at 2:37 PM

$FBLG buy alert, retesting the 75 cents, if it holds, we see abouve 85, break that and we could see $1 today.

0 · Reply

Niddi Jun. 26 at 2:33 PM

$FBLG Heading back to $1

1 · Reply

JMJTrading Jun. 26 at 2:10 PM

Headed to $FBLG with SLS profits! 4.55 million share float FBLG announced a definitive agreement for a $9.0 million private placement. They secured $3.0 million with up to $6.0 million in potential additional gross proceeds upon the full exercise of accompanying warrants. $FBLG) is executing a very clean, steady move to the upside so far this morning. break 85 cents and this will soar. $MTEN $GPUS $SLS @LosersMakeMillions @DavidScott @topstockalerts

0 · Reply

Stock_Catcher Jun. 26 at 12:31 PM

$FBLG FibroBiologics Announces up to $9.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules

0 · Reply

Market Cap	3.96M
Revenue (ttm)	0.00
Net Income (ttm)	-18.65M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	83,900
Avg Vol	134,564
Day's Range	N/A - N/A
Shares Out	6.08M
Stochastic %K	12%
Beta	1.14
Analysts	Sell
Price Target	$8.00